Wockhardt Sells Iv Fluids Business To Baxter India
Wockhardt Life Sciences has hived off its IV fluids business to Baxter India, Indian arm of the $7-billion US healthcare major, Baxter Healthcare International, for Rs 195 crore ($40 million). This is part of Wockhardt